- Home
- BRNS vs XCUR Comparison
BRNS vs XCUR Comparison
Compare BRNS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRNS | XCUR |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 26.6M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BRNS | XCUR |
|---|---|---|
| Price | $0.67 | $2.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 20.8K | 10.2K |
| Earning Date | 05-07-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $2.78 |
| 52 Week High | $2.91 | $11.00 |
Technical Indicators
Market Signals| Indicator | BRNS | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 30.03 |
| Support Level | $0.66 | N/A |
| Resistance Level | $0.76 | $4.23 |
| Average True Range (ATR) | 0.06 | 0.21 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 50.08 | 5.02 |
Price Performance
Historical ComparisonAbout BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.